Scholars Central

Conference abstractPublished 18 May 2016

When value and credibility of pathologist are dependent on getting the diagnosis right quality assurance programs in anatomic pathology can drive improved patient and provider outcomes

Authors: Mark Priebe

QualityStar LLC, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Every year, 1.6 million Americans are diagnosed with cancer. Getting the diagnosis right the first time is critical to designing the appropriate treatment plan and therapy. Pathology and radiology play significant roles in the diagnostic process. When things go wrong, 46% of the errors in diagnosis come from Pathology and Radiology, while 97% of the cancer diagnosis is based on the pathology specimen. Over the past 20 years, multiple studies have shown that the rate of major discrepancies identified for cancer patients referred to another institution range from 4.2-13.1% yet published data indicates the current intralab Quality Assurance (QA) ability to detect these discrepancies is only 0.8-1.7%. This clearly identifies a gap in our current quality practice and an opportunity to improve quality assurance initiatives. This abstract reviews the formal Quality Assurance programs and how they can be utilized to provide continuous quality improvement resulting in positive patient and institution outcomes.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical & Experimental Pathology
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Mark Priebe”